Covid-19: Delirium May Be a Presenting Symptom in Elderly Patients
Study suggests delirium may be present without other typical Covid-19 symptoms Delirium is common...
Read More
FDA / Research
Covid-19: FDA Issues EUA for Regeneron’s Monoclonal Antibody Tx
Casirivimab/imdevimab authorized for ’mild to moderate’ Covid-19 Casirivimab and imdevimab, a...
Read More
Pfizer/BioNTech Submit EUA for Covid-19 Vaccine
Moderna is expected to follow shortly with its EUA submission As expected, Pfizer, Inc., along...
Read More
Covid-19:Viral Shedding From Virus Can Be Prolonged, But Infection Window is Not
No live virus detected beyond 9 days in symptomatic patients SARS-CoV-2 RNA shedding lasted as...
Read More
Covid-19: AstraZeneca Vax Up to 90% Effective in Interim Analysis
Lower dose appears more effective than higher dose in preventing infection, but the ’why’ is...
Read MorePeople Proving to Be Weakest Link for Apps Tracking COVID Exposure
Contact tracers in many states are stretched thin. Colorado is among the latest states to launch an app that aims to help, based on the COVID contact-tracing tool built by Apple and Google. But there’s a chicken-and-egg problem: More people will use them if they prove to work, but the apps become effective only if more people use them.
Read More
Covid-19: FDA Grants EUA for First At-Home Self-Test Kit
Patients can test themselves and get results in 30 minutes or less WASHINGTON —The FDA issued an...
Read More
Covid-19: Early Trial Results Show Immune Response for CoronaVac Vaccine
Neutralizing antibodies were lower than seen in recovered Covid patients Early data on the...
Read More
Hospital Mortality Higher for Critically Ill With COVID-19 Versus Flu
TUESDAY, Nov. 17, 2020 (HealthDay News) — The risk for hospital mortality is higher for...
Read MoreNebulized Interferon Beta-1a Promising for COVID-19
TUESDAY, Nov. 17, 2020 (HealthDay News) — Patients hospitalized with COVID-19 who receive...
Read More
Sixty-Day Outcomes Examined for Hospitalized COVID-19 Patients
TUESDAY, Nov. 17, 2020 (HealthDay News) — Almost 30 percent of patients hospitalized with...
Read More‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die
Scientists have found that some people have antibodies against parts of their own immune system, allowing viruses to multiply rapidly.
Read More
Covid-19: Moderna Announces High Vax Efficacy in Interim Trial Results
News comes on heels of Pfizer’s Covid-19 vaccine announcement And now it’s a horse race — Exactly...
Read MoreStanford vs. Harvard: Two Famous Biz Schools’ Opposing Tactics on COVID
While the Harvard Business School gently chided returnees to be on their best behavior, Stanford deployed green-vested enforcers and campus police who sometimes threatened students if they violated the rules. Both, apparently, succeeded.
Read MoreClots, Strokes and Rashes: Is COVID a Disease of the Blood Vessels?
COVID-19 can cause symptoms that go well beyond the lungs, from strokes to organ failure. To explain these widespread injuries, researchers are studying how the virus affects the vascular system.
Read More
Covid-19: Inhaled Interferon Shows Early Promise Over Placebo
Patients treated with INF-Beta-1a had faster recovery, less severe disease Patients hospitalized...
Read More
Fluvoxamine May Protect Against Covid-19 Progression
Fully remote study showed lower clinical deterioration over 15 days Treatment with the selective...
Read More
Convalescent Plasma in the Management of Moderate COVID-19
With only a handful of treatment options available for COVID-19, health systems are aligning...
Read More
Risk of Hospital Admission with COVID-19 Among Healthcare Workers
The coronavirus disease continues to spread, with more than 44 million cases and 1 million deaths...
Read MoreTime to Discuss Potentially Unpleasant Side Effects of COVID Shots? Scientists Say Yes.
From the likelihood of achy, flu-like side effects to the need for two doses, weeks apart, consumers need to know now what to expect when vaccines to prevent COVID-19 roll out.
Read More